Loading…

Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity

5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT...

Full description

Saved in:
Bibliographic Details
Published in:IUBMB life 2016-12, Vol.68 (12), p.985-993
Main Authors: Chen, Weihai, Wang, Xiaqing, Yan, Minmin, Wang, Yan, Xie, Shixue, Li, Hong, Li, Ming
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 993
container_issue 12
container_start_page 985
container_title IUBMB life
container_volume 68
creator Chen, Weihai
Wang, Xiaqing
Yan, Minmin
Wang, Yan
Xie, Shixue
Li, Hong
Li, Ming
description 5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016
doi_str_mv 10.1002/iub.1580
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1834996801</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834996801</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183</originalsourceid><addsrcrecordid>eNpd0c1KxDAQAOAgij-r4BNIwIuXaiZp2vSoi3-oCKLnkrZTzdJta5Oq1YuP4DP6JKbs6sEEMoF8DDMZQnaBHQJj_Mj02SFIxVbIJkgOQSQlrP7dQ7FBtqydMb9ilqyTDR7HSQwh2yQfd9iidlhQXcxNbazrtDNNTZuSyu_Pr6eh6Jq3wXVD67QHSPmU6sdmlPTmigOnbdcUfY6WamqxtsaZ90UKLEvM3ZhJ1860dsifGmdyqnNnXowbtslaqSuLO8s4IQ9np_fTi-D69vxyenwdtAKABShAg8hikSWS5XkYSi19IxBx5XfEszLkRSljBRln46kSZCxUAIphBEpMyMEir6_0uUfr0rmxOVaVrrHpbepJmCSRYuDp_j86a_qu9tV5FXollIq92luqPptjkbadmetuSH-_1YNgAV5NhcPfO7B0HFfqx5WO40ovH07GKH4A0d2G-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844993887</pqid></control><display><type>article</type><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</creator><creatorcontrib>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</creatorcontrib><description>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</description><identifier>ISSN: 1521-6543</identifier><identifier>EISSN: 1521-6551</identifier><identifier>DOI: 10.1002/iub.1580</identifier><identifier>PMID: 27797140</identifier><identifier>CODEN: IULIF8</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>5‐hydroxytryptamine 2C receptor ; Animals ; Antipsychotic Agents - administration &amp; dosage ; antipsychotics ; Avoidance Learning ; conditioned avoidance response ; Conditioning (Psychology) - drug effects ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Male ; MK212 ; MK801‐induced hyperlocomotion ; Motor Activity - drug effects ; Pyrazines - administration &amp; dosage ; Rats, Sprague-Dawley ; Serotonin Receptor Agonists - administration &amp; dosage</subject><ispartof>IUBMB life, 2016-12, Vol.68 (12), p.985-993</ispartof><rights>2016 International Union of Biochemistry and Molecular Biology</rights><rights>2016 International Union of Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27797140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Weihai</creatorcontrib><creatorcontrib>Wang, Xiaqing</creatorcontrib><creatorcontrib>Yan, Minmin</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Xie, Shixue</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><title>IUBMB life</title><addtitle>IUBMB Life</addtitle><description>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</description><subject>5‐hydroxytryptamine 2C receptor</subject><subject>Animals</subject><subject>Antipsychotic Agents - administration &amp; dosage</subject><subject>antipsychotics</subject><subject>Avoidance Learning</subject><subject>conditioned avoidance response</subject><subject>Conditioning (Psychology) - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Evaluation, Preclinical</subject><subject>Male</subject><subject>MK212</subject><subject>MK801‐induced hyperlocomotion</subject><subject>Motor Activity - drug effects</subject><subject>Pyrazines - administration &amp; dosage</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin Receptor Agonists - administration &amp; dosage</subject><issn>1521-6543</issn><issn>1521-6551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpd0c1KxDAQAOAgij-r4BNIwIuXaiZp2vSoi3-oCKLnkrZTzdJta5Oq1YuP4DP6JKbs6sEEMoF8DDMZQnaBHQJj_Mj02SFIxVbIJkgOQSQlrP7dQ7FBtqydMb9ilqyTDR7HSQwh2yQfd9iidlhQXcxNbazrtDNNTZuSyu_Pr6eh6Jq3wXVD67QHSPmU6sdmlPTmigOnbdcUfY6WamqxtsaZ90UKLEvM3ZhJ1860dsifGmdyqnNnXowbtslaqSuLO8s4IQ9np_fTi-D69vxyenwdtAKABShAg8hikSWS5XkYSi19IxBx5XfEszLkRSljBRln46kSZCxUAIphBEpMyMEir6_0uUfr0rmxOVaVrrHpbepJmCSRYuDp_j86a_qu9tV5FXollIq92luqPptjkbadmetuSH-_1YNgAV5NhcPfO7B0HFfqx5WO40ovH07GKH4A0d2G-A</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Chen, Weihai</creator><creator>Wang, Xiaqing</creator><creator>Yan, Minmin</creator><creator>Wang, Yan</creator><creator>Xie, Shixue</creator><creator>Li, Hong</creator><creator>Li, Ming</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><author>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>5‐hydroxytryptamine 2C receptor</topic><topic>Animals</topic><topic>Antipsychotic Agents - administration &amp; dosage</topic><topic>antipsychotics</topic><topic>Avoidance Learning</topic><topic>conditioned avoidance response</topic><topic>Conditioning (Psychology) - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Evaluation, Preclinical</topic><topic>Male</topic><topic>MK212</topic><topic>MK801‐induced hyperlocomotion</topic><topic>Motor Activity - drug effects</topic><topic>Pyrazines - administration &amp; dosage</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin Receptor Agonists - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Weihai</creatorcontrib><creatorcontrib>Wang, Xiaqing</creatorcontrib><creatorcontrib>Yan, Minmin</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Xie, Shixue</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>IUBMB life</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Weihai</au><au>Wang, Xiaqing</au><au>Yan, Minmin</au><au>Wang, Yan</au><au>Xie, Shixue</au><au>Li, Hong</au><au>Li, Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</atitle><jtitle>IUBMB life</jtitle><addtitle>IUBMB Life</addtitle><date>2016-12</date><risdate>2016</risdate><volume>68</volume><issue>12</issue><spage>985</spage><epage>993</epage><pages>985-993</pages><issn>1521-6543</issn><eissn>1521-6551</eissn><coden>IULIF8</coden><abstract>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27797140</pmid><doi>10.1002/iub.1580</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1521-6543
ispartof IUBMB life, 2016-12, Vol.68 (12), p.985-993
issn 1521-6543
1521-6551
language eng
recordid cdi_proquest_miscellaneous_1834996801
source Wiley-Blackwell Read & Publish Collection
subjects 5‐hydroxytryptamine 2C receptor
Animals
Antipsychotic Agents - administration & dosage
antipsychotics
Avoidance Learning
conditioned avoidance response
Conditioning (Psychology) - drug effects
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Male
MK212
MK801‐induced hyperlocomotion
Motor Activity - drug effects
Pyrazines - administration & dosage
Rats, Sprague-Dawley
Serotonin Receptor Agonists - administration & dosage
title Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T03%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repeated%20administration%20of%205%E2%80%90hydroxytryptamine%202C%20agonist%20MK212%20produces%20a%20sensitization%20effect%20of%20antipsychotic%20activity&rft.jtitle=IUBMB%20life&rft.au=Chen,%20Weihai&rft.date=2016-12&rft.volume=68&rft.issue=12&rft.spage=985&rft.epage=993&rft.pages=985-993&rft.issn=1521-6543&rft.eissn=1521-6551&rft.coden=IULIF8&rft_id=info:doi/10.1002/iub.1580&rft_dat=%3Cproquest_pubme%3E1834996801%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1844993887&rft_id=info:pmid/27797140&rfr_iscdi=true